[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fB7fuW3TjP80xBVnr4I2aqMAWUc7h9oT6RXK2RLAORRg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":37,"phaseBuckets":47,"rows":54},"Edwards Lifesciences",[4],127,false,45,0,42523,1,124,[14,17,20,23,26,29,32,35],{"name":15,"count":16},"Aortic Valve Stenosis",15,{"name":18,"count":19},"Aortic Stenosis",14,{"name":21,"count":22},"Mitral Regurgitation",12,{"name":24,"count":25},"Mitral Valve Insufficiency",11,{"name":27,"count":28},"Heart Failure",10,{"name":30,"count":31},"Aortic Valve Disease",9,{"name":33,"count":34},"Mitral Valve Regurgitation",8,{"name":36,"count":34},"Cardiovascular Diseases",[38,43],{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT04482062","TRISCEND II Pivotal Trial","2025-12-05","Optimal Medical Therapy",{"nctId":44,"briefTitle":45,"date":46,"intervention":42},"NCT04097145","Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial","2027-12-31",[48,49,50,51,52,53],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[55,91],{"intervention":42,"totalTrials":56,"cells":57},2,{"EARLY_PHASE1":58,"PHASE1":60,"PHASE2":62,"PHASE3":64,"PHASE4":66,"NA":68},{"trials":59,"activeCount":9},[],{"trials":61,"activeCount":9},[],{"trials":63,"activeCount":9},[],{"trials":65,"activeCount":9},[],{"trials":67,"activeCount":9},[],{"trials":69,"activeCount":56,"soonestReadout":41},[70,81],{"nctId":44,"briefTitle":45,"status":71,"phases":72,"primaryCompletion":46,"completion":73,"start":74,"enrollment":75,"conditions":76,"interventions":80},"RECRUITING",[53],"2031-12-31","2019-12-11",1270,[77,78,79],"Tricuspid Regurgitation","Tricuspid Valve Insufficiency","Tricuspid Valve Disease",[42],{"nctId":39,"briefTitle":40,"status":82,"phases":83,"primaryCompletion":41,"completion":84,"start":85,"enrollment":86,"conditions":87,"interventions":90},"ACTIVE_NOT_RECRUITING",[53],"2030-06-27","2021-04-09",864,[88,78,79,89,36,27],"Tricuspid Valve Regurgitation","Heart Valve Diseases",[42],{"intervention":92,"totalTrials":11,"cells":93},"Guideline Directed Medical Therapy",{"EARLY_PHASE1":94,"PHASE1":96,"PHASE2":98,"PHASE3":100,"PHASE4":102,"NA":104},{"trials":95,"activeCount":9},[],{"trials":97,"activeCount":9},[],{"trials":99,"activeCount":9},[],{"trials":101,"activeCount":9},[],{"trials":103,"activeCount":9},[],{"trials":105,"activeCount":9},[106],{"nctId":107,"briefTitle":108,"status":109,"phases":110,"primaryCompletion":111,"completion":112,"start":113,"enrollment":22,"conditions":114,"interventions":117},"NCT03016975","Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)","TERMINATED",[53],"2019-07-19","2022-09-20","2017-06-01",[115,21,116],"Functional Mitral Regurgitation","Mitral Insufficiency",[92]]